Home/Pipeline/CREATe Platform

CREATe Platform

Cell & Gene Therapy Components

ResearchActive

Key Facts

Indication
Cell & Gene Therapy Components
Phase
Research
Status
Active
Company

About VRG Therapeutics

VRG Therapeutics is a private, pre-clinical stage biotech based in Budapest, Hungary, specializing in AI-powered miniprotein drug discovery. The company's core technology platform, comprising ISEP™ and CREATe™, enables the rapid design and optimization of therapeutic peptides with sub-nanomolar affinity and extreme selectivity. While initially targeting neurodegenerative diseases, VRG's versatile platform supports a diverse pipeline and collaborations in cell and gene therapy, positioning it to address high-value, undrugged targets. The company appears to be in a growth phase, securing grants, expanding its team, and initiating an international roadshow.

View full company profile